Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $117.4600 (-4.74%) ($117.1500 - $123.9200) on Mon. Aug. 8, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.15% (three month average) | RSI | 41 | Latest Price | $117.4600(-4.74%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -3.2% a day on average for past five trading days. | Weekly Trend | LGND declines -2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) ARKG(51%) | Factors Impacting LGND price | LGND will decline at least -1.075% in a week (0% probabilities). VIXM(-15%) TLT(-15%) UUP(-8%) IPO(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.075% (StdDev 2.15%) | Hourly BBV | 0 () | Intraday Trend | -4.7% | | | |
|
Resistance Level | $130.67 | 5 Day Moving Average | $127.8(-8.09%) | 10 Day Moving Average | $131.47(-10.66%) | 20 Day Moving Average | $130.67(-10.11%) | To recent high | -15.2% | To recent low | 5.1% | Market Cap | $1.888b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |